Suzette Dutch

Suzette Dutch, Managing Partner of Triathlon Medical Ventures, has 20 years venture investing and 10 years operating experience in pharmaceuticals, surgical devices and diagnostics. At Senmed she served on the investment committee from its creation in 1987 and led the strategic planning, clinical/regulatory, market and business development due diligence efforts for start-ups through later stage investments. Previously she was responsible for strategic marketing for Sentron’s surgical stapling business until its sale to Ethicon. Prior to that she held various positions in clinical studies design, market research, and corporate planning at SmithKline integrating the acquisitions of Allergan, Beckman, and Clinical Laboratories. She has an MBA from Wharton in Finance and Decision Science, and a BA in economics from Case Western Reserve University. She is currently on the Board of Directors of Biovex and an observer on Akebia, and was on the Board of Directors of Renal Solutions prior to its acquisition by Fresenius.